Related Experiment Video
Updated: Apr 18, 2026

Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
Intestinal epithelium in inflammatory bowel disease
1Department of Gastroenterology, Medical Section, Herlev Hospital, University of Copenhagen , Herlev , Denmark.
The intestinal epithelium, a key physical barrier, is vital for gut health. Its dysfunction contributes to inflammatory bowel disease (IBD) by increasing permeability and disrupting immune balance, offering potential therapeutic targets.
Area of Science:
- Gastroenterology and Immunology
- Epithelial Biology
- Inflammatory Bowel Disease Research
Background:
- The intestinal epithelium forms a critical physical barrier against luminal microbiota.
- Specialized intestinal epithelial cells (IECs) maintain intestinal homeostasis and contribute to the mucosal immune system.
- Epithelial barrier dysfunction is implicated in inflammatory bowel disease (IBD) pathogenesis.
Purpose of the Study:
- To elucidate the role of the intestinal epithelium in IBD pathogenesis.
- To understand how epithelial barrier defects contribute to immune dysregulation in IBD.
- To identify potential therapeutic targets within the intestinal epithelium for IBD treatment.
Main Methods:
- This study focuses on the functional and structural aspects of the intestinal epithelium.
- Investigated the interactions between IECs and immune cells in the lamina propria.
- Utilized models to study epithelial permeability and immune homeostasis.
Main Results:
- Dysregulation of the intestinal epithelial barrier increases intestinal permeability.
- Abnormal IEC-immune cell interactions disrupt intestinal immune homeostasis.
- These epithelial defects are linked to the clinical course of IBD.
Conclusions:
- The intestinal epithelium plays a significant role in IBD pathogenesis.
- Understanding epithelial barrier function is crucial for comprehending IBD inflammation.
- Targeting the intestinal epithelium may offer novel therapeutic strategies for IBD.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Clinical Manifestations

